Morphosys AG (NASDAQ: MOR)
|
|
---|---|
Pricing data not available |
Open: | $ n/a | Volume: | n/a | |
---|---|---|---|---|
High: | $ n/a | Yield(%) | n/a | |
Low: | $ n/a | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | n/a | |
EPS ($) | n/a | Shares Out: | n/a |
% Price Change (last 4 weeks): | 0.00 |
---|---|
% Price Change (last 13 weeks): | 4.64 |
% Price Change (last 26 weeks): | 5.16 |
% Price Change (last 52 weeks): | 140.00 |
% Price Change (year to date): | 91.52 |
Return on Equity (%): | -184.65 |
---|---|
Return on Assets (%): | -8.55 |
Return on Invested Capital (%): | -30.33 |
Gross Profit Margin (%): | 71.02 |
---|---|
Net Profit Margin (%): | -79.63 |
Operating Profit Margin (%): | -101.26 |
50-day Moving Average: | $18.41 |
---|---|
200-day Moving Average: | $14.43 |
Avg. Daily Vol. (last 50 days): | 50,642 |
Avg. Daily Vol. (last 200 days): | 1,056,509 |
52-wk high: | $n/a |
52-wk low: | $n/a |
Bid: | $n/a |
Ask: | $n/a |
MorphoSys AG is a biopharmaceutical company, which engages in the development and commercialization of cancer therapeutics. Its clinical programs focus on Pelabresib and Tulmimetostat. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.
|
Morphosys AG
Semmelweisstrasse 7 Planegg BV 82152 Phone: 49.89.89927.0 Fax: 49.89.89927.222 http://www.morphosys.de |
Earnings (1year) ($): | -3.44 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 0.36 |
Cash Flow ($): | -1.26 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 5.27 |
Price/Book (x): | 27.48 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 2.84 |
---|---|
Current Ratio (x): | 3.08 |
LT Debt/Equity (x): | 515.44 |
Total Debt/Equity (x): | 526.17 |